Strides Pharma Science Quarterly Results for Trading Insights
STAR • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹132 Cr
QSept 2025
Strides Pharma Science Quarterly Results Key Highlights
- Revenue of ₹1,248 Cr in Sept 2025 (+3.5% vs Mar 2025, +4.4% vs Sept 2024)
- Net Profit of ₹132 Cr in Sept 2025 (+53.5% vs Mar 2025, +83.3% vs Sept 2024)
- EBITDA of ₹249 Cr in Sept 2025 (+20.9% vs Mar 2025)
- Operating Margin of 18.0% in Sept 2025 (+2.0pp vs Mar 2025)
- Earnings Per Share of ₹13.84 in Sept 2025 (+55.2% vs Mar 2025)
Strides Pharma Science Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 1,248 | 1,206 | 1,128 | 1,195 | 1,030 | 3.5% | 4.4% |
| Net Profit (₹ Cr) | 132 | 86 | 106 | 72 | 10 | - | - |
| EBITDA (₹ Cr) | 249 | 206 | 218 | 209 | 142 | - | - |
| EPS (₹) | 13.84 | 8.92 | 10.81 | 7.81 | 1.98 | - | - |
| Operating Margin (%) | 18.0% | 16.0% | 19.0% | 15.0% | 15.0% | - | - |
Strides Pharma Science Share Price Trend Around Quarterly Results
Visualize Strides Pharma Science's 1-year price movement across quarterly results — ideal for logging trades in Strides Pharma Science share price
chart using Tickjournal. All values in ₹.
Related Pages for Strides Pharma Science
Additional stock information and data for STAR
Revenue Trend (₹ Cr)
Sept 2024
1,195
Jun 2025
1,128
Mar 2025
1,206
Sept 2025
1,248
Net Profit Trend (₹ Cr)
Sept 2024
72
Jun 2025
106
Mar 2025
86
Sept 2025
132
Operating Margin Trend (%)
Sept 2024
15.0%
Jun 2025
19.0%
Mar 2025
16.0%
Sept 2025
18.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Strides Pharma Science quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹422,330.94 Cr | 1760.2 | 14,875 | 3,125 | +10.8% | - | 21.0% | 135.4 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6642.5 | 2,860 | 689 | +7.1% | - | 24.1% | 255.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3936.8 | 3,219 | 591 | +11.3% | - | 18.4% | 224.4 |
|
Cipla
Sept 2025 |
₹121,238.47 Cr | 1530.8 | 7,716 | 1,353 | +12.0% | - | 17.5% | 91.5 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,829.57 Cr | 1256.2 | 9,135 | 1,337 | +1.1% | - | 14.6% | 77.6 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores